Australasian Cerebral Palsy Clinical Trials Network (AusCP-CTN): optimising interventions and effective services for children with Cerebral Palsy

脑性麻痹（CP）很常见，残疾可能是渐进的，因此医疗保健负担巨大（占国内生产总值的0.14%）。我们的临床试验网络将改善早期发现，并开发新的干预措施，以改善CP儿童及其家庭的身体，认知和健康结果。从国家CP注册中心招募将解决临床上重要的问题，并测试有效治疗的实施。新的临床实践指南将确保国际翻译。

Cerebral Palsy (CP) is common and disability can be progressive so the heathcare burden is immense (0.14% GDP). Our Clinical trials network will improve early detection and develop new interventions to improve physical, cognitive and health outcomes for children with CP and their families. Recruitment from the national CP Register will address clinically important questions and test implementation of effective treatments. New Clinical Practice Guidelines will ensure translation internationally.